Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Compugen Ltd (NASDAQ:CGEN)

6.75
Delayed Data
As of Jul 27
 +0.15 / +2.27%
Today’s Change
4.32
Today|||52-Week Range
7.79
+5.63%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$333.8M

Company Description

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

Contact Information

Compugen Ltd.
Azrieli Center
Holon Tel Aviv 58858
P:(723) 765-8585
Investor Relations:

Employees

Shareholders

Other institutional8.76%
Mutual fund holders6.04%
Individual stakeholders--

Top Executives

Anat Cohen-DayagPresident & Chief Executive Officer
Ari KrashinChief Operating & Financial Officer
Zurit LevineVice President-Research & Discovery
Tsipi Keren-LehrerVice President-Business Development
Dorit AmitayVice President-Human Resources